- AU$6.60bn
- AU$13.88bn
- AU$2.53bn
Morningstar lifts fair value for Australia's Challenger on strong growth forecast
Brief: Challenger Posts Q1 Total Life Sales A$2.5 Billion
Brief: Challenger Posts FY Adjusted Net Income Of A$455.5 Million
Australia's Challenger hits over five-year high on strong results
Brief: Challenger Ltd Says It Expects FY26 Normalised Basic EPS Between 66 And 72 AU Cents Per Share
Brief: Challenger Says Tal Dai-Ichi Life Receives Regulatory Approvals
Citi raises PT on Australia's Challenger, sees benefits in regulator proposed measures
Japan's Dai-ichi Life could double investment target to at least $4 billion
Brief: Dai-Ichi Life Holdings: Australia Subsidiary TAL To Acquire Additional 4.8% Stake In Challenger For About A$247 Million (About 22.9 Billion Yen) From AP Liberty GP
Brief: Dai-Ichi Life Hd - Australian Subsidiary Will Acquire Additional Minority Investment In Challenger For About 22.9 Billion Yen
Brief: Challenger Welcomes APRA's Consultation On Capital Settings
Australia's Challenger rises; Macquarie raises PT on strong quarterly results
Australia's Challenger jumps on higher quarterly life annuity sales; UBS hikes PT
Australia's Challenger gains on higher quarterly life annuity sales
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: TAL Dai-Ichi Life Australia Entered Conditional Agreement To Acquire Shares In Challenger
Australia's Challenger soars on Dai-ichi Life signing deal to buy stake